Wilmington Savings Fund Society’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.14M Sell
106,605
-526
-0.5% -$30.2K 0.14% 119
2026
Q1
$6.5M Sell
107,131
-4,045
-4% -$236K 0.15% 111
2025
Q4
$6M Sell
111,176
-5,083
-4% -$245K 0.14% 118
2025
Q3
$5.24M Sell
116,259
-30,571
-21% -$1.43M 0.13% 136
2025
Q2
$6.8M Buy
146,830
+443
+0.3% +$21.7K 0.12% 139
2025
Q1
$8.93M Sell
146,387
-9,315
-6% -$543K 0.17% 111
2024
Q4
$8.81M Sell
155,702
-3,979
-2% -$222K 0.16% 113
2024
Q3
$8.26M Buy
159,681
+73,383
+85% +$3.44M 0.15% 125
2024
Q2
$3.58M Sell
86,298
-474
-0.5% -$21.2K 0.14% 127
2024
Q1
$4.71M Buy
+86,772
New +$4.42M 0.18% 113
2023
Q3
$5.5M Sell
94,776
-68
-0.1% -$4.17K 0.24% 100
2023
Q2
$6.07M Sell
94,844
-1,782
-2% -$119K 0.25% 102
2023
Q1
$6.7M Sell
96,626
-1,196
-1% -$84.4K 0.3% 90
2022
Q4
$7.04M Sell
97,822
-967
-1% -$72.9K 0.32% 87
2022
Q3
$7.02M Sell
98,789
-1,974
-2% -$143K 0.34% 75
2022
Q2
$7.76M Sell
100,763
-3,718
-4% -$283K 0.36% 73
2022
Q1
$7.63M Sell
104,481
-545
-0.5% -$36.6K 0.3% 82
2021
Q4
$6.55M Sell
105,026
-8,730
-8% -$512K 0.24% 101
2021
Q3
$6.73M Sell
113,756
-4,367
-4% -$288K 0.26% 95
2021
Q2
$7.89M Buy
118,123
+606
+0.5% +$39.5K 0.3% 84
2021
Q1
$7.42M Sell
117,517
-2,024
-2% -$126K 0.3% 91
2020
Q4
$7.42M Buy
119,541
+707
+0.6% +$43.5K 0.31% 85
2020
Q3
$7.17M Sell
118,834
-829
-0.7% -$49.9K 0.33% 80
2020
Q2
$7.04M Sell
119,663
-5,613
-4% -$336K 0.35% 77
2020
Q1
$6.98M Sell
125,276
-1,362
-1% -$83.2K 0.41% 74
2019
Q4
$8.13M Buy
126,638
+2,379
+2% +$136K 0.41% 84
2019
Q3
$6.3M Sell
124,259
-3,372
-3% -$158K 0.34% 94
2019
Q2
$5.79M Sell
127,631
-3,968
-3% -$185K 0.31% 105
2019
Q1
$6.28M Sell
131,599
-3,082
-2% -$154K 0.34% 104
2018
Q4
$7M Sell
134,681
-8,417
-6% -$452K 0.42% 86
2018
Q3
$8.88M Sell
143,098
-3,340
-2% -$198K 0.47% 77
2018
Q2
$8.1M Buy
146,438
+2,226
+2% +$120K 0.45% 77
2018
Q1
$9.12M Sell
144,212
-623
-0.4% -$40.1K 0.52% 62
2017
Q4
$8.88M Sell
144,835
-5,261
-4% -$329K 0.48% 65
2017
Q3
$9.57M Buy
150,096
+1,025
+0.7% +$59.8K 0.55% 60
2017
Q2
$8.31M Sell
149,071
-301
-0.2% -$16.4K 0.49% 62
2017
Q1
$8.12M Sell
149,372
-8,059
-5% -$442K 0.49% 61
2016
Q4
$9.2M Sell
157,431
-2,369
-1% -$130K 0.58% 50
2016
Q3
$8.62M Sell
159,800
-3,052
-2% -$196K 0.54% 55
2016
Q2
$12M Sell
162,852
-8,008
-5% -$566K 0.76% 38
2016
Q1
$10.9M Sell
170,860
-1,647
-1% -$104K 0.7% 43
2015
Q4
$11.9M Sell
172,507
-3,845
-2% -$254K 0.74% 43
2015
Q3
$10.4M Buy
176,352
+10,732
+6% +$681K 0.67% 46
2015
Q2
$11M Sell
165,620
-357
-0.2% -$23.5K 0.64% 50
2015
Q1
$10.7M Sell
165,977
-2,187
-1% -$137K 0.61% 55
2014
Q4
$9.93M Buy
168,164
+1,897
+1% +$107K 0.56% 59
2014
Q3
$8.51M Sell
166,267
-922
-0.6% -$46.1K 0.48% 62
2014
Q2
$8.11M Sell
167,189
-3,012
-2% -$148K 0.45% 67
2014
Q1
$8.84M Sell
170,201
-1,119
-0.7% -$59.5K 0.49% 60
2013
Q4
$9.11M Buy
171,320
+897
+0.5% +$45.7K 0.51% 59
2013
Q3
$7.89M Buy
170,423
+2,632
+2% +$116K 0.49% 61
2013
Q2
$7.5M Buy
+167,791
New +$7.28M 0.48% 60

Other funds holding BMY

Wilmington Savings Fund Society's BMY Position: Q2 2026 in Review

Wilmington Savings Fund Society reduced its Bristol-Myers Squibb (BMY) stake by 0.49% in Q2 2026, selling an estimated $30.2K and leaving 106,605 shares worth $6.14M. The position accounts for 0.14% of the portfolio, ranked #119.

Wilmington Savings Fund Society first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $12M in Q2 2016. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Wilmington Savings Fund Society held 106,605 shares of Bristol-Myers Squibb worth $6.14M as of Q2 2026.
  • Wilmington Savings Fund Society sold 526 Bristol-Myers Squibb shares in Q2 2026, an estimated $30.2K.
  • Bristol-Myers Squibb made up 0.14% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #119 holding.
  • Wilmington Savings Fund Society first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Wilmington Savings Fund Society's Bristol-Myers Squibb position peaked at $12M in Q2 2016.
  • 2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.